Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|February 14, 2022
Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid LeukemiaClaudia Tregnago, Maddalena Benetton, Ambra Da Ros, et al.
Cancers|July 24, 2021
NPM1 Mutational Status Underlines Different Biological Features in Pediatric AMLClaudia Tregnago, Maddalena Benetton, Davide Padrin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 20, 2025
Leukemic Cells Hijack Stromal Bioelectricity to Reprogram the Bone Marrow Niche via CaV1.2-Dependent MechanismsAmbra Da Ros, Maddalena Benetton, Giulia Borella, et al.
Nature Communications|May 7, 2026
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapyMartina Pigazzi, Silvia Merlini, Ambra Da Ros, et al.
Blood Advances|January 23, 2026
Advancing Precision Therapy in Pediatric Acute Myeloid Leukemia Through PDX Models and Mitochondrial TargetingAmbra Da Ros, Alberto Peloso, Giorgia Longo, et al.
Iscience|November 24, 2021
The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamicsElena Porcù, Maddalena Benetton, Valeria Bisio, et al.
Biomedicines|July 27, 2022
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupMaddalena Benetton, Pietro Merli, Christiane Walter, et al.
Blood Advances|September 15, 2020
Thioridazine requires calcium influx to induce MLL-AF6-rearranged AML cell deathClaudia Tregnago, Ambra Da Ros, Elena Porcù, et al.
Blood|May 19, 2021
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemiaGiulia Borella, Ambra Da Ros, Giulia Borile, et al.
Pageof 1